IPG Investment Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

IPG Investment Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,410	Closed	-$5.23K	–	183
2022 Q4	$5.23K	Hold	1,410	–	–	﹤0.01%	139
2022 Q3	$7.05K	Hold	1,410	–	–	﹤0.01%	142
2022 Q2	$8K	Hold	1,410	–	–	﹤0.01%	159
2022 Q1	$10K	Hold	1,410	–	–	﹤0.01%	171
2021 Q4	$19K	Hold	1,410	–	–	﹤0.01%	204
2021 Q3	$32.4K	Hold	1,410	–	–	0.01%	129
2021 Q2	$61.9K	Buy	+1,410	New	+$78.5K	0.02%	139

Other funds holding ORTX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

IPG Investment Advisors's ORTX Position: Q1 2023 in Review

IPG Investment Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2023, closing a stake of 1,410 shares — an estimated $5.23K sold.

IPG Investment Advisors first reported a position in ORTX in Q2 2021 and held it in 7 quarters. The position peaked at $61.9K in Q2 2021. 35 funds tracked by Wall St. Rank hold ORTX as of Q1 2023.

IPG Investment Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
IPG Investment Advisors sold 1,410 Orchard Therapeutics plc American Depositary Shares shares in Q1 2023, an estimated $5.23K.
IPG Investment Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2021 and held it in 7 quarters.
IPG Investment Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $61.9K in Q2 2021.
35 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2023.

Based on IPG Investment Advisors's 13F filing for Q1 2023, filed 12 May 2023.